» Articles » PMID: 7544994

Immunohistology of Skin Pathergy Reaction in Behçet's Disease

Overview
Journal Br J Dermatol
Specialty Dermatology
Date 1995 Jun 1
PMID 7544994
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

The immunophenotypic characteristics of the skin pathergy reaction (SPR) at 48 h in Behçet's disease (BD) were investigated in 12 patients with BD and in five controls. The findings in 11 positive and one negative SPR lesions of patients with BD were evaluated in comparison with those of normal adjacent skin and with the negative pathergy biopsies from the controls. Positive SPR biopsies showed variable epidermal thickening and cell vacuolization, as well as subcorneal pustule formation. In the SPR dermis, a variable dense focal mononuclear cell (MNC) infiltrate was seen around vessels and skin appendages, extending into the deep dermis. The MNC infiltrate was predominantly composed of T lymphocytes and monocytes/macrophages. The majority of the T lymphocytes were CD4+, and almost all expressed CD45RO. Approximately half of the infiltrating cells strongly expressed HLA-DR. Neutrophils constituted less than 5% of the infiltrating cells, but were present as clusters of elastase-positive cells at the needle-prick sites. Vessels within the lesion showed marked congestion and endothelial swelling. The endothelial cells expressed ICAM-1 strongly, and E-selectin moderately. VCAM-1 was not expressed on endothelial cells. The basal and mid-epidermal layers of keratinocytes expressed HLA-DR and ICAM-1 strongly, particularly so in areas close to the dermal MNC infiltrates. In negative pathergy biopsies, there were increased numbers of neutrophils and a few small clusters of macrophages and T lymphocytes only at the needle-prick site, and the endothelial cells of vessels close to these areas expressed E-selectin weakly.(ABSTRACT TRUNCATED AT 250 WORDS)

Citing Articles

Innate immune responses in Behçet disease and relapsing polychondritis.

Shimizu J, Murayama M, Mizukami Y, Arimitsu N, Takai K, Miyabe Y Front Med (Lausanne). 2023; 10:1055753.

PMID: 37435539 PMC: 10331610. DOI: 10.3389/fmed.2023.1055753.


Immunopathogenesis of Behçet's disease.

Al-Obeidi A, Nowatzky J Clin Immunol. 2023; 253:109661.

PMID: 37295542 PMC: 10484394. DOI: 10.1016/j.clim.2023.109661.


Behçet's disease risk-variant HLA-B51/ERAP1-Hap10 alters human CD8 T cell immunity.

Cavers A, Kugler M, Ozguler Y, Al-Obeidi A, Hatemi G, Ueberheide B Ann Rheum Dis. 2022; 81(11):1603-1611.

PMID: 35922122 PMC: 9585993. DOI: 10.1136/ard-2022-222277.


The Roles of Monocytes and Macrophages in Behçet's Disease With Focus on M1 and M2 Polarization.

Hirahara L, Takase-Minegishi K, Kirino Y, Iizuka-Iribe Y, Soejima Y, Yoshimi R Front Immunol. 2022; 13:852297.

PMID: 35359926 PMC: 8963421. DOI: 10.3389/fimmu.2022.852297.


Pathergy Phenomenon.

Ergun T Front Med (Lausanne). 2021; 8:639404.

PMID: 34113630 PMC: 8185024. DOI: 10.3389/fmed.2021.639404.